Prosus NV Vs. Akero Therapeutics, Inc. Industry Stock Comparison

Buy

65

PROSY
Prosus NV

Last Price:

$14.52

Seasonality Move:

8.09%

Sell

42

AKRO
Akero Therapeutics, Inc.

Last Price:

$46.51

Seasonality Move:

34.06%

Buy

65

Prosus NV (PROSY) is a Buy

Is Prosus NV a Buy, Sell or Hold?

The current Prosus NV [PROSY] share price is $14.52. The Score for PROSY is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
PROSY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

42

Akero Therapeutics, Inc. (AKRO) is a Sell

Is Akero Therapeutics, Inc. a Buy, Sell or Hold?

The current Akero Therapeutics, Inc. [AKRO] share price is $46.49. The Score for AKRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PROSY Stock Price Chart

What is Prosus NV's stock price today?

The Prosus NV share price today is $14.52

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PROSY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics, Inc.'s stock price today?

The Akero Therapeutics, Inc. share price today is $46.49

The current trend is relatively stagnant and AKRO is experiencing slight selling pressure.

PROSY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.53	Buy
Relative Strength Index (14 RSI):	77.12	Buy
Chaikin Money Flow:	310577	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(12.71 - 14.17)	Buy
Bollinger Bands (100):	(10.67 - 13.01)	Buy

AKRO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	50.64	Buy
Chaikin Money Flow:	-210515	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(43.82 - 47.14)	Buy
Bollinger Bands (100):	(45.39 - 52.97)	Sell

PROSY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	14.33	Buy
20-day SMA:	13.7	Buy
50-day SMA:	12.74	Buy
200-day SMA:	10.24	Buy
8-day EMA:	14.26	Buy
20-day EMA:	13.76	Buy
50-day EMA:	12.92	Buy
200-day EMA:	10.77	Buy

AKRO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	46.59	Sell
20-day SMA:	45.79	Buy
50-day SMA:	46.95	Sell
200-day SMA:	44.66	Buy
8-day EMA:	46.38	Buy
20-day EMA:	46.27	Buy
50-day EMA:	46.94	Sell
200-day EMA:	43.98	Buy

Prosus NV Earnings Growth & PROSY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics, Inc. Earnings Growth & AKRO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and a decrease next year of $0.52 per share.

Prosus NV Technical Analysis

	Sep 25	Sep 26	Sep 29	Sep 30	Oct 1	Oct 2	Oct 3	Oct 6	Oct 7	Oct 8
	Sep					Oct
	25	26	29	30	01	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics, Inc. Technical Analysis

	Sep 25	Sep 26	Sep 29	Sep 30	Oct 1	Oct 2	Oct 3	Oct 6	Oct 7	Oct 8
	Sep					Oct
	25	26	29	30	01	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):